Saratoga Research & Investment Management Has Boosted Its Biogen (BIIB) Holding; As Target (TGT) Valuation Declined, Shareholder London Co Of Virginia Increased Position

February 15, 2018 - By Adrian Mccoy

London Co Of Virginia increased its stake in Target Corp (TGT) by 38.07% based on its latest 2017Q3 regulatory filing with the SEC. London Co Of Virginia bought 1.19 million shares as the company’s stock declined 14.90% while stock markets rallied. The institutional investor held 4.30M shares of the department and specialty retail stores company at the end of 2017Q3, valued at $253.87M, up from 3.12 million at the end of the previous reported quarter. London Co Of Virginia who had been investing in Target Corp for a number of months, seems to be bullish on the $40.96B market cap company. The stock increased 1.99% or $1.47 during the last trading session, reaching $75.35. About 7.39 million shares traded. Target Corporation (NYSE:TGT) has declined 16.51% since February 15, 2017 and is downtrending. It has underperformed by 33.21% the S&P500.

Saratoga Research & Investment Management increased its stake in Biogen Inc (BIIB) by 2.87% based on its latest 2017Q3 regulatory filing with the SEC. Saratoga Research & Investment Management bought 3,947 shares as the company’s stock declined 13.45% while stock markets rallied. The institutional investor held 141,509 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $44.31M, up from 137,562 at the end of the previous reported quarter. Saratoga Research & Investment Management who had been investing in Biogen Inc for a number of months, seems to be bullish on the $62.64B market cap company. The stock decreased 6.60% or $20.91 during the last trading session, reaching $296.08. About 5.43 million shares traded or 331.66% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 15, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Since January 9, 2018, it had 0 buys, and 1 insider sale for $1.92 million activity.

Saratoga Research & Investment Management, which manages about $1.40B and $1.31 billion US Long portfolio, decreased its stake in Johnson & Johnson (NYSE:JNJ) by 7,568 shares to 258,642 shares, valued at $33.63M in 2017Q3, according to the filing. It also reduced its holding in Accenture Ltd New (NYSE:ACN) by 19,686 shares in the quarter, leaving it with 232,224 shares, and cut its stake in Omnicom Group (NYSE:OMC).

Investors sentiment increased to 1.13 in 2017 Q3. Its up 0.25, from 0.88 in 2017Q2. It improved, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Baystate Wealth Management Ltd reported 1,513 shares. Utd Ser Automobile Association has 264,030 shares for 0.24% of their portfolio. Raymond James Na holds 0.1% in Biogen Inc. (NASDAQ:BIIB) or 4,659 shares. Fayez Sarofim & Com invested in 0.02% or 9,713 shares. Bancorpsouth owns 1,823 shares for 0.06% of their portfolio. Suntrust Banks stated it has 19,807 shares or 0.03% of all its holdings. 218,485 were accumulated by State Of New Jersey Common Pension Fund D. Fdx Advsrs Inc reported 4,942 shares or 0.04% of all its holdings. Associated Banc holds 0.24% of its portfolio in Biogen Inc. (NASDAQ:BIIB) for 14,026 shares. Chem National Bank has 0.06% invested in Biogen Inc. (NASDAQ:BIIB). Asset One Company Ltd reported 362,566 shares stake. Cibc World Markets Corp has invested 0.15% in Biogen Inc. (NASDAQ:BIIB). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment invested 0.26% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Virginia Retirement Et Al has invested 0.41% in Biogen Inc. (NASDAQ:BIIB). Delta Asset Mgmt Tn accumulated 109 shares or 0.01% of the stock.

Among 32 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 8 Hold. Therefore 75% are positive. Biogen Idec Inc. had 111 analyst reports since July 23, 2015 according to SRatingsIntel. As per Friday, August 25, the company rating was maintained by Robert W. Baird. The stock has “Neutral” rating by Citigroup on Tuesday, June 7. Canaccord Genuity maintained the shares of BIIB in report on Wednesday, January 24 with “Hold” rating. The rating was initiated by Mizuho on Tuesday, November 8 with “Buy”. As per Monday, November 7, the company rating was upgraded by PiperJaffray. Cantor Fitzgerald maintained the stock with “Hold” rating in Tuesday, July 25 report. Bernstein upgraded Biogen Inc. (NASDAQ:BIIB) rating on Monday, July 27. Bernstein has “Outperform” rating and $385 target. The stock has “Hold” rating by Morgan Stanley on Wednesday, June 14. UBS maintained the shares of BIIB in report on Wednesday, October 25 with “Neutral” rating. The firm has “Buy” rating by Cowen & Co given on Tuesday, August 25.

London Co Of Virginia, which manages about $13.96B US Long portfolio, decreased its stake in Edgewell Pers Care Co by 52,587 shares to 949,988 shares, valued at $69.13 million in 2017Q3, according to the filing. It also reduced its holding in Southwest Airls Co (NYSE:LUV) by 29,454 shares in the quarter, leaving it with 986,017 shares, and cut its stake in Gatx Corp (NYSE:GMT).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: